Effekt selektiver und nicht selektiver nichtsteroidaler Antiphlogistika ...

Literaturverzeichnis
DUBOIS, R. N., S. B. ABRAMSON, L. CROFFORD, R. A. GUPTA, L. S. SIMON, L.
B. A. VAN DE PUTTE u. P. E. LIPSKY (1998):
Cyclooxygenase in biology and disease.
FASEB J. 12, 1063 - 1073
EDWARDS, G. B., u. C. J. PROUDMAN (1994):
An analysis of 75 cases of intestinal obstruction caused by pedunculated lipomas.
Equine Vet. J. 26, 18 - 21
EYSKER, M., J. H. BOERSEMA, G. C. GRINWIS, F. N. KOOYMAN u. J. POOT
(1997):
Controlled dose confirmation study of a 2% moxidectin equine gel against equine
internal parasites in The Netherlands.
Vet. Parasitol. 70, 165 - 173
FECHNER, G., J. VAN PEZOLD, O. LUZAR, S. HAUSER, R. H. TOLBA u. S. C.
MÜLLER (2009):
Modified Spectrometry (O2C Device) of intraoperative microperfusion predicts organ
function after kidney transplantation: a pilot study.
Transplant. Proc. 41, 3575 - 3579
FITZGERALD, G. A., u. P. LOLL (2001):
COX in a crystal ball: current status and future promise of prostaglandin research.
J. Clin. Invest. 107, 1335 - 1337
FOREMAN, J. H., u. R. RUEMMLER (2011):
Phenylbutazone and Flunixin meglumine used singly or in combination in
experimental lameness in horses.
Equine Vet. J. 43, 12 - 17
FOREMAN, J. H., B. E. BERGSTROM, K. S. GOLDEN, J. J. ROARK, D. S. COREN,
C. R. FOREMAN u. S. A. SCHUMACHER (2012):
Dose titration of the clinical efficacy of intravenously administered flunixin meglumine
in a reversible model of equine foot lameness.
Equine Vet. J. 44, 17 - 20
FRANGOGIANNIS, N. G., M. L. LINDSEY, L. H. MICHAEL, K. A. YOUKER, R. B.
BRESSLER, L. H. MENDOZA, R. N. SPENGLER, C. W. SMITH u. M. L. ENTMAN
(1998):
Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating
the cytokine cascade in experimental canine myocardial ischemia/reperfusion.
Circulation 98, 699–710
184